Endpoint protection and response platforms cover everything from AI-powered ransomware detection to insider risk monitoring.
Stock market movers: futures dip in a holiday week as ZIM soars on a $4.2B buyout, biotechs rally on Phase 3 data, and WPM slides on a $4.3B deal—read now.
Compass plans to submit a NDA for its psilocybin-based psychedelic, COMP360 in TRD during Q4 2026. Credit: AnastasiaNi/Shutterstock.com. Compass Pathways’ stock is ...
Novartis announced positive Phase III results from the RemIND trial showing that the oral BTK inhibitor remibrutinib achieved significantly higher complete response rates than placebo in three major ...
(PRESS RELEASE) BASEL, 13-Feb-2026 — / EuropaWire / — Novartis has announced final Phase III results from the ALIGN study evaluating Vanrafia (atrasentan) in adults with IgA nephropathy (IgAN), ...
In 2025, the number of homes available for sale in the Lehigh Valley was down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results